Can we vaccinate against Type 1 diabetes? - Wikidata - awgldk - TriplyDB

Can we vaccinate against Type 1 diabetes?

Can we vaccinate against Type 1 diabetes?

http://www.wikidata.org/entity/Q36296386

about

Reply to "Tolerogenic insulin peptide therapy precipitates type 1 diabetes".Clinical optimization of antigen specific modulation of type 1 diabetes with the plasmid DNA platform.

P2860

Q36378893-F0F87A9A-19D0-41F6-B654-CE9B3A62C327 Q36709163-9A4410F4-A5B3-47BB-8F33-6246E69DA2FA

P2860

Can we vaccinate against Type 1 diabetes?

http://www.wikidata.org/entity/Q36296386

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Can we vaccinate against Type 1 diabetes?

@ast

Can we vaccinate against Type 1 diabetes?

@en

type

label

Can we vaccinate against Type 1 diabetes?

@ast

Can we vaccinate against Type 1 diabetes?

@en

prefLabel

Can we vaccinate against Type 1 diabetes?

@ast

Can we vaccinate against Type 1 diabetes?

@en

P1433

Q36296386-3942E6C0-AB7D-4EE6-B87F-657E1493FE6B

P1476

Q36296386-936FA7F3-5E74-439B-A56C-00B41DC56E25

P2860

Q36296386-00196462-4210-42FA-9B19-71236A1806F5

Q36296386-0BC59592-DEE8-404F-B682-7042C5D03646

Q36296386-10DF8976-2E55-4C3F-A91C-E7A26145FA06

Q36296386-1A47F92E-AE4C-4DFB-B305-1BA9634D61E1

Q36296386-1D34D083-0904-4BB9-88FC-6FE30EF43DCC

Q36296386-262BFC32-919A-436B-B65F-D419D81F78A6

Q36296386-29239A6E-0538-44CD-8849-4E2639049AEC

Q36296386-339666C3-52BD-4340-AE30-94402B336C30

Q36296386-34AAFF8B-460E-4004-A0FA-FF95C4A14437

Q36296386-408336B3-6A3E-47E5-83D8-F9696ACB8931

P304

Q36296386-A047DA8D-5975-4456-AD0E-9380661E4200

P31

Q36296386-95411E11-67DC-431F-9610-24C011319406

P356

Q36296386-24AD7BC6-4AF8-46E2-A48C-DEAAFE73CD16

P478

Q36296386-C04F734C-2AD5-4174-9058-1A2D23A6A0DD

P50

Q36296386-2C434C76-DDC0-4002-A40F-E5B4ED35AB08

P577

Q36296386-67D5E214-75D6-462C-99CD-1D4C48E71EFD

P698

Q36296386-509CA1DB-73A2-40DB-9D3A-F6A30B355C27

P921

Q36296386-098AF57D-7116-48DB-AB03-B299309D9C1D

P932

Q36296386-1664146A-48F6-4300-B3A6-CCD975B374B3

P356

P1433

F1000 biology reports

P1476

Can we vaccinate against Type 1 diabetes?

@en

P2860

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

Immunological mechanisms of allergen-specific immunotherapy

Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death

A function for interleukin 2 in Foxp3-expressing regulatory T cells

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction.

Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects

Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy.

Naturally arising human CD4 T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppression

Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope

P304

19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3410/B4-19

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23112807

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

3463895

http://www.w3.org/2001/XMLSchema#string